SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease-Reference-Cited by-同舟云学术

SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease

Published:2022-03-15 Issue:3 Volume:10 Page:319-329
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:UEG Journal

Author:

Duengelhoef Paul¹²,Hartl Johannes¹³^ORCID,Rüther Darius¹³^ORCID,Steinmann Silja¹³,Brehm Thomas T.¹⁴,Weltzsch Jan Philipp¹³,Glaser Fabian¹³,Schaub G. M.¹⁴,Sterneck Martina¹,Sebode Marcial¹³,Weiler‐Normann Christina¹³,Addo Marylyn M.¹⁴⁵,Lütgehetmann Marc⁴⁶,Haag Friedrich²,Schramm Christoph¹³⁷⁸,Schulze zur Wiesch Julian¹⁴,Lohse Ansgar W.¹³⁴⁸

Affiliation:

1. Department of Internal Medicine University Medical Center Hamburg‐Eppendorf Hamburg Germany

2. Institute of Immunology University Medical Center Hamburg‐Eppendorf Hamburg Germany

3. European Reference Network on Hepatological Diseases (ERN RARE‐LIVER) Hamburg Germany

4. Partner Site Hamburg‐Lübeck‐Borstel‐Riems German Center for Infection Research (DZIF) Hamburg Germany

5. Department for Clinical Immunology of Infectious Diseases Bernhard‐Nocht‐Institute for Tropical Medicine Hamburg Germany

6. Institute of Medical Microbiology, Virology and Hygiene University Medical Center Hamburg‐Eppendorf Hamburg Germany

7. Martin‐Zeitz Center for Rare Diseases University Medical Center Hamburg‐Eppendorf Hamburg Germany

8. Hamburg Center for Translational Immunology (HCTI) Hamburg Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ueg2.12218

Reference23 articles.

1. SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients

2. Examining the Immunological Effects of COVID-19 Vaccination in Patients with Conditions Potentially Leading to Diminished Immune Response Capacity – The OCTAVE Trial

3. Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic

4. Evaluation of the automated LIAISON® SARS-CoV-2 TrimericS IgG assay for the detection of circulating antibodies

5. Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acceptance, safety, and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in patients with primary biliary cholangitis;Heliyon;2024-04

2. Safety and effectiveness of SARS‐CoV‐2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire‐based, cross‐sectional study;Hepatology Research;2024-02

3. Insight into COVID-19 associated liver injury: Mechanisms, evaluation, and clinical implications;Hepatology Forum;2024

4. Immunogenicity and risk factors for poor humoral immune response to SARS-CoV-2 vaccine in patients with autoimmune hepatitis: a systematic review and meta-analysis;Revista Española de Enfermedades Digestivas;2024

5. Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients;Journal of Hepatology;2024-01